RxDoctor Payments Data

Ahmed Abou-Zamzam, MD

Vascular Surgery · Loma Linda, CANPI 1558306795

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,941 of the $9,166 with a category attached, or 86.6%. 25 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 29.2% of the total. Reporting peaked in 2019 at $2,157 and has fallen 50.1% since, to $1,076 in 2025.

$9,166in general payments, 2019–2025

Across 143 payments — averaging $64.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$3K
  • Cook Medical LLC$2K
  • Silk Road Medical, Inc.$2K
  • Medtronic$2K
  • Bolton Medical Inc$359
  • Bard Peripheral Vascular, Inc.$256
  • plus $1K from 19 others
$11,088in research payments, 2019–2025

Across 4 payments — averaging $2772.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$11K

What the payments were for

  • Travel & lodging$1,22513%
  • Food & beverage$7,94187%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,166 in reported general payments places this provider in the 65th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California →

Medicare billing

Part B allowed, 2024
$125,877
Medicare patients
700
Services billed
1,261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$19,036
Cilostazol62$1,644
ClopidogrelClopidogrel Bisulfate38$414
Atorvastatin Calcium29$216

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Loma Linda

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →